Hosted on MSN20d
Henry Schein targets $4.80-$4.94 EPS for 2025, supported by restructuring and strategic growthThis partnership aligns with the strategic plan and is anticipated to support long-term growth ... impact due to supply chain adjustments. Henry Schein demonstrated solid progress in Q4 2024 ...
Henry Schein is supporting the Special Olympics Healthy Athletes screenings at the Special Olympics World Winter Games March 8-15, 2025, in Turin, Italy, by donating a range of oral ...
As you can see from the chart above the percentage of shares that are sold short for Henry Schein has declined since its last report. This does not mean that the stock is going to rise in the near ...
Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, warranting a soft 'buy' rating for the stock. Read the full report.
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as they position themselves for future growth in the competitive diabetes ...
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...
These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, has received the 2025 World’s Most Ethical Companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results